
mAbxience CDMO
Емкость одноразового использования емкостью 24 000 л для производства антителоподобных молекул GMP
Compliance: ANVISA (Brazil B-GMP), COFEPRIS, ISO, TITCK (Turkish Health Authorities), ICH, MHRA (UK GMP), ANMAT (Argentina nueva GMP), ISP (Chile BPM), EMA (EU GMP), World Health Organization (GMP / HACCP), UAE Ministry of Health & Prevention, SFDA (Saudi Food & Drug Authority)
Markets: EMA (EU), INVIMA (Colombia), Russian Health Authorities, ANMAT (Argentina), Остальной мир, COFEPRIS (Mexico), EDE (UAE), ISP (Chile), ANVISA (Brazil), DIGEMID (Peru), Turkish Health Authorities, SFDA (Saudi Arabia)
Batch Size: Large, Medium
Region: LATAM
Use: Human
Services: Analytical / QC services, Manufacturing services
Therapeutic Areas of Expertise (ATC): (B) Blood and blood forming organs, (D) Dermatologicals, (N) Nervous system, (J) Antiinfectives for systemic use, (R) Respiratory system, (P) Antiparasitic products, insecticides and repellents, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism
Category / Product: BIOLOGICS

Region: LATAM
Services: Development services, Manufacturing services
Compliance: ANMAT (Argentina nueva GMP)
Markets: ANMAT (Argentina), Остальной мир
Category / Product: BIOLOGICS

mAbxience CDMO
Емкость одноразового использования емкостью 24 000 л для разработки антителоподобных молекул и производства GMP, от разработки клеточной линии до коммерческой фармацевтической субстанции.
Batch Size: Large, Small, Medium
Compliance: TITCK (Turkish Health Authorities), ANVISA (Brazil B-GMP), COFEPRIS, ISO, ICH, FDA (cGMP), PMDA/MHLW (Japan GMP), Health Canada (Canada GMP), MHRA (UK GMP), ANMAT (Argentina nueva GMP), TGA (Australia GMP), Roszdravnadzor (Russia GMP), ECOVADIS, ISP (Chile BPM), French Service-Public (CIR), World Health Organization (GMP / HACCP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP), UAE Ministry of Health & Prevention, SFDA (Saudi Food & Drug Authority)
Markets: EMA (EU), MHRA (UK), INVIMA (Colombia), MSPAS (Guatemala), Russian Health Authorities, FDA (USA), PMDA (Japan), Health Canada (Canada), ANMAT (Argentina), Остальной мир, COFEPRIS (Mexico), EDE (UAE), ISP (Chile), ANVISA (Brazil), DIGEMID (Peru), Turkish Health Authorities, MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia)
Services: Development services, Analytical / QC services, Manufacturing services, Quality Assurance services
Use: Human, Veterinary
Therapeutic Areas of Expertise (ATC): (B) Blood and blood forming organs, (D) Dermatologicals, (N) Nervous system, (J) Antiinfectives for systemic use, (R) Respiratory system, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (H) Systemic hormonal preparations excl. sex hormones and insulins, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism
Region: Europe
Category / Product: BIOLOGICS

53Biologics
53Biologics — это комплексный CDMO по биологическим препаратам, созданный для поддержания прогресса от доклинических до коммерческих поставок. Мы созданы для этого.
Batch Size: Large, Small, Medium
BSL (Biological Safety Level): 1, 2
Compliance: ISO, FDA (cGMP), World Health Organization (GMP / HACCP), EMA (EU GMP)
Markets: FDA (USA), Health Canada (Canada), ANMAT (Argentina), COFEPRIS (Mexico), ISP (Chile), ANVISA (Brazil), DIGEMID (Peru), MSPAS (Guatemala), INVIMA (Colombia), MHRA (UK), EMA (EU), TGA (Australia)
Services: Development services, Analytical / QC services, Logistics, Manufacturing services, Quality Assurance services, Regulatory services
Use: Human, Veterinary
Region: Europe
Category / Product: BIOLOGICS

Bilthoven Biologicals BV
Многопрофильные предприятия GMP для лекарственных субстанций и лекарственных препаратов.
Markets: EMA (EU), MHRA (UK)
Batch Size: Large, Small, Medium
BSL (Biological Safety Level): 1, 2
Services: Development services, Logistics, Analytical / QC services, Manufacturing services, Quality Assurance services, Regulatory services, Packaging
Use: Human
Compliance: EMA (EU GMP)
Category / Product: FDF / DRUG PRODUCTS, АНАЛИТИЧЕСКАЯ ОЦР, BIOLOGICS
Region: Europe

CZ Vaccines
Центр клинических исследований
Services: Development services, Logistics, Analytical / QC services, Manufacturing services, Quality Assurance services, Regulatory services, Packaging
Markets: EMA (EU), ANVISA (Brazil), CDSCO (India)
Use: Human
BSL (Biological Safety Level): 1, 2
Compliance: ISO, ANVISA (Brazil B-GMP), World Health Organization (GMP / HACCP), EMA (EU GMP)
Batch Size: Small
Category / Product: FDF / DRUG PRODUCTS, BIOLOGICS
Therapeutic Areas of Expertise (ATC): (R) Respiratory system, (G) Genito urinary system and sex hormones, (A) Digestive tract and metabolism
Region: Europe

CARBOGEN AMCIS
Разработка и среднемасштабное производство cGMP, включая хроматографию.
Use: Human, Veterinary
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), CDSCO (India), MFDS (South Korea), TGA (Australia)
Services: Development services, Analytical / QC services, Manufacturing services, Quality Assurance services
Compliance: ISO, FDA (cGMP), PMDA/MHLW (Japan GMP), World Health Organization (GMP / HACCP)
Batch Size: Small, Medium
Category / Product: АНАЛИТИЧЕСКАЯ ОЦР, PARTICLE ENGINEERING, BIOLOGICS, CHEMICAL-SYNTHETIC
OEB (Occupational Exposure Banding): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)
Region: Europe

CARBOGEN AMCIS
Разработка и производство cGMP высокоэффективных API, включая конъюгаты антитело-лекарственное средство (ADC).
Services: Development services, Analytical / QC services, Regulatory services, Quality Assurance services, Manufacturing services
Markets: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), MFDS (South Korea), Turkish Health Authorities, CDSCO (India), TGA (Australia)
Compliance: FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), EMA (EU GMP), World Health Organization (GMP / HACCP)
Use: Human, Veterinary
Therapeutic Areas of Expertise (ATC): (V09-10) Radiopharmaceuticals, (N) Nervous system, (D) Dermatologicals, (B) Blood and blood forming organs, (R) Respiratory system, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (C) Cardiovascular system, (A) Digestive tract and metabolism
Batch Size: Small, Medium
OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)
Category / Product: PARTICLE ENGINEERING, АНАЛИТИЧЕСКАЯ ОЦР, BIOLOGICS, CHEMICAL-SYNTHETIC
Region: Europe

HIPRA Biotech Services
Комплексные внутренние возможности: от разработки клеточной линии до коммерческого производства.
Services: Development services, Logistics, Analytical / QC services, Packaging, Regulatory services, Quality Assurance services, Manufacturing services
Markets: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia)
Compliance: DIGEMID, FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, INVIMA, ISP (Chile BPM), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)
BSL (Biological Safety Level): 1, 2
Use: Human
Batch Size: Large, Small, Medium
OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)
Region: Europe
Category / Product: BIOLOGICS

Services: Development services, Logistics, Analytical / QC services, Packaging, Regulatory services, Quality Assurance services, Manufacturing services
Markets: EMA (EU)
Compliance: ISO, EMA (EU GMP), World Health Organization (GMP / HACCP)
BSL (Biological Safety Level): 1, 2
Use: Human
Batch Size: Large, Medium
Therapeutic Areas of Expertise (ATC): (J) Antiinfectives for systemic use, (R) Respiratory system, (G) Genito urinary system and sex hormones
Category / Product: FDF / DRUG PRODUCTS, BIOLOGICS
Region: Europe

Green Phoenix Labs GmbH
Лицензированный сайт ATMP в Германии. Производство GMP и выпуск партий QP для клеточной и тканевой терапии.
Services: Development services, Analytical / QC services, Packaging, Regulatory services, Quality Assurance services, Manufacturing services
Markets: EMA (EU)
BSL (Biological Safety Level): 1, 2
Use: Human
Controlled Substances: Lowest potential for abuse, Lower potential for abuse, Low potential for abuse
Therapeutic Areas of Expertise (ATC): (S) Sensory organs, (N) Nervous system, (D) Dermatologicals, (B) Blood and blood forming organs, (R) Respiratory system, (M) Musculoskeletal system, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism
Batch Size: Small, Medium
OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)
Compliance: EMA (EU GMP)
Category / Product: FDF / DRUG PRODUCTS, АНАЛИТИЧЕСКАЯ ОЦР, BIOLOGICS
Region: Europe

HIPRA Biotech Services
Комплексные внутренние возможности: от разработки клеточной линии до коммерческого производства.
Services: Development services, Logistics, Analytical / QC services, Packaging, Regulatory services, Quality Assurance services, Manufacturing services
Markets: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia)
Compliance: DIGEMID, FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, INVIMA, ISP (Chile BPM), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)
BSL (Biological Safety Level): 1, 2
Use: Human, Veterinary
Batch Size: Large, Small, Medium
OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)
Category / Product: FDF / DRUG PRODUCTS, BIOLOGICS
Region: Europe
Зарегистрируйтесь, чтобы разблокировать полный каталог с контактными данными и местоположениями.
+35 дополнительные возможности
Создать бесплатную учетную записьAre you a pharmaceutical company seeking a reliable CMO or CDMO partner to accelerate your drug development process? Look no further than MAI CDMO Network. Our advanced search platform connects you with a vast network of qualified contract manufacturers and development organizations worldwide.
Why Choose MAI CDMO Network?
How MAI CDMO Network Works
Key Benefits of Partnering with a CMO/CDMO
Featured Services
Ready to Find Your Ideal CMO/CDMO Partner? Register Now
Explore our platform today and discover how MAI CDMO Network can help you achieve your drug development goals.